$15.80
+0.04 (+0.25%)
Open$15.86
Previous Close$15.76
Day High$15.94
Day Low$15.50
52W High$17.57
52W Low$3.67
Volume—
Avg Volume39.7K
Market Cap84.80M
P/E Ratio1.86
EPS$7.89
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
-12.5% upside
Current
$15.80
$15.80
Target
$13.83
$13.83
$9.36
$13.83 avg
$17.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 815.3K | 116.64M | 118.58M |
| Net Income | -8,532,130 | -21,434,773 | -22,545,743 |
| Profit Margin | -1,046.4% | -18.4% | -19.0% |
| EBITDA | -32,166,152 | -23,823,087 | -23,688,809 |
| Free Cash Flow | — | -12,084,786 | -12,382,292 |
| Rev Growth | — | -8.2% | -9.4% |
| Debt/Equity | — | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |